Mohan Dhyani, MD

Department of Psychiatry, Shri Guru Ram Rai Institute of Medical and Health Sciences, Uttarakhand, India

  • 3Articles
  • 1KReads
  • 2025–2026Active
  • 6Collaborators
  • 1Citations

About

Mohan Dhyani, MD, is affiliated with the Department of Psychiatry at Shri Guru Ram Rai Institute of Medical and Health Sciences in Uttarakhand, India. Dhyani has published research from 2025 to 2026 focusing on neuropsychiatric conditions including schizophrenia and schizoaffective disorders, cognition, genetics, and neurology. The work addresses topics such as osmotic demyelination syndrome with extrapyramidal symptoms, lumateperone-associated urticarial rash in schizophrenia, and neuropsychiatric manifestations of cerebrotendinous xanthomatosis. Frequent collaborators include Shobit Garg, Abhijeet Anand, Amrit Pattojoshi, Astha Jain, and Neetu Garg.

Publications

PCC
Osmotic Demyelination Syndrome Presenting as EPS
Case Report

Osmotic Demyelination Syndrome Presenting as EPS

April 21, 2026

A 44-year-old woman was initially referred for presumed domperidone-induced extrapyramidal symptoms, but further workup uncovered a complex interplay of hyponatremia, demyelination, and neuroleptic hypersensitivity.
, , , et al
PCC
Lumateperone-Induced Urticarial Rash in Schizophrenia
Case Report

Lumateperone-Induced Urticarial Rash in Schizophrenia

November 13, 2025

This report describes an instance of acute generalized urticaria immediately following an initial dose of lumateperone in a 43-year-old man with schizophrenia.
, ,
PCC
Cerebrotendinous Xanthomatosis: Unraveling Prominent Neuropsychiatric Symptoms and MCI
Case Report

Cerebrotendinous Xanthomatosis: Unraveling Prominent Neuropsychiatric Symptoms and MCI

October 30, 2025

A 51-year-old woman with an 8-month history of significant cognitive decline and behavioral changes, including forgetfulness, irritability, and anger outbursts, received an initial diagnosis of MCI.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe